| 1 | Sezary Syndrome | 39.8% |
| 2 | Lymphoma | 37.8% |
| 3 | Autoimmune Lymphoproliferative Syndrome | 35.2% |
| 4 | Infectious Mononucleosis | 33.1% |
| 5 | Sarcoidosis | 31.1% |
| 6 | Heavy Chain Disease | 28.5% |
| 7 | Hodgkin Disease | 27.6% |
| 8 | Lymphoma, Non-Hodgkin | 27.6% |
| 9 | Leukemia, T-Cell | 27.5% |
| 10 | Leukemia, B-Cell | 27.5% |
| 11 | Agammaglobulinemia | 25.7% |
| 12 | Granuloma | 23.7% |
| 13 | Plasmacytoma | 23.3% |
| 14 | Composite Lymphoma | 23.1% |
| 15 | Lymphangioleiomyomatosis | 22.8% |
| 16 | Lymphoma, Follicular | 22.7% |
| 17 | T-Cell Lymphoma | 22.7% |
| 18 | Mantle cell lymphoma | 22.7% |
| 19 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 22.7% |
| 20 | Leukemia, Large Granular Lymphocytic | 22.7% |
| 21 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 22.7% |
| 22 | Primary amyloidosis | 22.1% |
| 23 | Adenitis | 20.5% |
| 24 | Histiocytosis | 20.5% |
| 25 | Lymphadenitis | 20.5% |
| 26 | Lymphangitis | 20.5% |
| 27 | Lymphedema | 20.5% |
| 28 | Splenic Diseases | 20.5% |
| 29 | Thymus Hyperplasia | 20.5% |
| 30 | Pseudolymphoma | 20.5% |
| 31 | Lymphadenopathy | 20.5% |
| 32 | Lymphoma, T-Cell, Cutaneous | 20.3% |
| 33 | Lymphoma, AIDS-Related | 20.3% |
| 34 | Enteropathy-Associated T-Cell Lymphoma | 20.3% |
| 35 | Primary Effusion Lymphoma | 20.3% |
| 36 | Mycosis Fungoides | 19.1% |
| 37 | Lymphomatoid Papulosis | 19.1% |
| 38 | Plasmablastic lymphoma | 19.1% |
| 39 | Waldenstrom Macroglobulinemia | 19% |
| 40 | Multiple Myeloma | 19% |
| 41 | Paraproteinemias | 18.6% |
| 42 | Sarcoidosis, Pulmonary | 17.4% |
| 43 | Lymphomatoid Granulomatosis | 17.2% |
| 44 | Monoclonal Gammopathy of Undetermined Significance | 16.5% |
| 45 | Lymphangiectasis, Intestinal | 16% |
| 46 | Lymphocele | 15.5% |
| 47 | Lymphatic Abnormalities | 15.5% |
| 48 | Thymus Neoplasms | 15.3% |
| 49 | Hypergammaglobulinemia | 15.1% |
| 50 | Burkitt Lymphoma | 14.6% |
| 51 | Transfusion Reaction | 14.3% |
| 52 | Hypotensive Transfusion Reaction | 14.3% |
| 53 | Leukemia, Plasma Cell | 13.8% |
| 54 | Elephantiasis | 13.3% |
| 55 | Hypersplenism | 13.3% |
| 56 | Elephantiasis Nostras Verrucosa | 13.3% |
| 57 | Mucocutaneous Lymph Node Syndrome | 12.2% |
| 58 | Autoimmune Diseases | 11.9% |
| 59 | Hypersensitivity | 11.9% |
| 60 | Immunologic Deficiency Syndromes | 11.9% |
| 61 | Immune reconstitution syndrome | 11.9% |
| 62 | Immune Reconstitution Inflammatory Syndrome | 11.9% |
| 63 | Histiocytic Disorders, Malignant | 10.2% |
| 64 | Splenic Infarction | 10.2% |
| 65 | Splenic Neoplasms | 10.2% |
| 66 | Histiocytosis, Langerhans-Cell | 10% |
| 67 | Cryoglobulinemia | 9.9% |
| 68 | Lymphohistiocytosis, Hemophagocytic | 9.9% |
| 69 | Schnitzler Syndrome | 9.9% |
| 70 | Erdheim-Chester Disease | 9.9% |
| 71 | POEMS Syndrome | 8.2% |
| 72 | Splenic Rupture | 8.2% |
| 73 | Disseminated Intravascular Coagulation | 8% |
| 74 | Protein S Deficiency | 8% |
| 75 | Thymoma | 7.9% |
| 76 | Autoimmune thrombocytopenia | 7.6% |
| 77 | Immune thrombocytopenic purpura | 7.6% |
| 78 | Lymphopenia | 7.6% |
| 79 | Malignant histiocytosis | 7.4% |
| 80 | Histiocytic sarcoma | 7.4% |
| 81 | Thrombocytopenic purpura | 7.4% |
| 82 | Thrombocythemia, Essential | 7.4% |
| 83 | Anemia | 6.8% |
| 84 | Blood Coagulation Disorders | 6.8% |
| 85 | Blood Platelet Disorders | 6.8% |
| 86 | Bone Marrow Diseases | 6.8% |
| 87 | Hemorrhagic Disorders | 6.8% |
| 88 | Immune Complex Diseases | 6.8% |
| 89 | Leukocyte Disorders | 6.8% |
| 90 | Methemoglobinemia | 6.8% |
| 91 | Pancytopenia | 6.8% |
| 92 | Polycythemia | 6.8% |
| 93 | Sulfhemoglobinemia | 6.8% |
| 94 | Antiphospholipid Syndrome | 6.8% |
| 95 | Thrombophilia | 6.8% |
| 96 | Latex allergy | 6.8% |
| 97 | Erythrocytosis | 6.8% |
| 98 | Glomerulonephritis, Membranoproliferative | 6.8% |
| 99 | Transfusion-Related Acute Lung Injury | 6.7% |
| 100 | Thrombasthenia | 6.1% |
| 101 | Antithrombin III Deficiency | 6.1% |
| 102 | Protein C Deficiency | 6.1% |
| 103 | Splenosis | 6% |
| 104 | Thrombocytosis | 5.8% |
| 105 | Job Syndrome | 5.8% |
| 106 | Eosinophilic Granuloma | 5.7% |
| 107 | Wiskott-Aldrich Syndrome | 5.6% |
| 108 | Afibrinogenemia | 5.5% |
| 109 | Factor VII Deficiency | 5.5% |
| 110 | Factor X Deficiency | 5.5% |
| 111 | Factor XII Deficiency | 5.5% |
| 112 | Hemophilia A | 5.5% |
| 113 | Activated Protein C Resistance | 5.5% |
| 114 | Factor II deficiency | 5.5% |
| 115 | Factor VIII Deficiency | 5.5% |
| 116 | Factor V deficiency | 5.5% |
| 117 | Factor XI Deficiency | 5.5% |
| 118 | Hypoprothrombinemias | 5.5% |
| 119 | Environmental Illness | 5.4% |
| 120 | Bone Marrow Neoplasms | 5.3% |
| 121 | Vitamin K Deficiency | 5.3% |
| 122 | Lupus Erythematosus, Systemic | 5.2% |
| 123 | Pregnancy Complications, Hematologic | 5.2% |
| 124 | Hematologic Neoplasms | 5.2% |
| 125 | Overlap syndrome | 5.2% |
| 126 | Addison Disease | 5.1% |
| 127 | Pemphigus | 5.1% |
| 128 | Autoimmune thyroiditis | 5.1% |
| 129 | Primary Adrenal Insufficiency | 5.1% |
| 130 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 5% |
| 131 | Autoimmune hepatitis | 5% |
| 132 | Hemoglobinuria, Paroxysmal | 4.9% |
| 133 | Leukemoid Reaction | 4.9% |
| 134 | Polycythemia Vera | 4.9% |
| 135 | Chronic granulomatous disease | 4.6% |
| 136 | Hydrops Fetalis | 4.6% |
| 137 | anaphylaxis | 4.4% |
| 138 | Anemia, Hemolytic | 4.4% |
| 139 | Anemia, Macrocytic | 4.4% |
| 140 | Eosinophilia | 4.4% |
| 141 | Food Allergy | 4.4% |
| 142 | Hypoproteinemia | 4.4% |
| 143 | Leukopenia | 4.4% |
| 144 | Thrombocytopenia | 4.4% |
| 145 | Leukostasis | 4.4% |
| 146 | MYELODYSPLASTIC SYNDROME | 4.4% |
| 147 | Anaphylactic shock | 4.4% |
| 148 | Anemia, Diamond-Blackfan | 4.3% |
| 149 | Kernicterus | 4.2% |
| 150 | Latent Autoimmune Diabetes in Adults | 4.1% |
| 151 | Dermatitis Herpetiformis | 4.1% |
| 152 | Kounis Syndrome | 4.1% |
| 153 | Purpura, Thrombotic Thrombocytopenic | 4% |
| 154 | HIV Infections | 4% |
| 155 | Serum Sickness | 3.8% |
| 156 | Asthma, Aspirin-Induced | 3.8% |
| 157 | Anemia, Sickle Cell | 3.6% |
| 158 | Thalassemia | 3.6% |
| 159 | Respiratory Hypersensitivity | 3.5% |
| 160 | Rheumatoid Arthritis | 3.4% |
| 161 | Juvenile arthritis | 3.4% |
| 162 | Anemia, Neonatal | 3.4% |
| 163 | Leukocytosis | 3.4% |
| 164 | Pelger-Huet Anomaly | 3.4% |
| 165 | Sick Building Syndrome | 3.4% |
| 166 | Pleocytosis | 3.4% |
| 167 | Multiple Chemical Sensitivity | 3.4% |
| 168 | Graves Disease | 3.4% |
| 169 | Urticaria | 3.3% |
| 170 | Vasculitis, Leukocytoclastic, Cutaneous | 3.3% |
| 171 | Anti-Glomerular Basement Membrane Disease | 3.3% |
| 172 | HTLV-I Infections | 3.3% |
| 173 | Primary Myelofibrosis | 3.3% |
| 174 | Agranulocytosis | 3.3% |
| 175 | Anemia, Megaloblastic | 3.3% |
| 176 | Lymphocytosis | 3.3% |
| 177 | Myelofibrosis | 3.3% |
| 178 | Myeloid Metaplasia | 3.3% |
| 179 | Milk Allergy | 3.3% |
| 180 | Hypoalbuminemia | 3.3% |
| 181 | Wheat Hypersensitivity | 3.3% |
| 182 | Hypereosinophilic syndrome | 3.3% |
| 183 | bone marrow fibrosis | 3.3% |
| 184 | Thrombotic Microangiopathies | 3.3% |
| 185 | Hemolytic-Uremic Syndrome | 3% |
| 186 | Sickle Cell Trait | 2.8% |
| 187 | Purpura, Hyperglobulinemic | 2.8% |
| 188 | Fanconi Anemia | 2.7% |
| 189 | Neutropenia | 2.7% |
| 190 | Myasthenia Gravis | 2.7% |
| 191 | Uveomeningoencephalitic Syndrome | 2.7% |
| 192 | Mastocytosis | 2.7% |
| 193 | Drug Eruptions | 2.7% |
| 194 | Ecchymosis | 2.7% |
| 195 | Petechiae | 2.7% |
| 196 | Purpura | 2.7% |
| 197 | Granulomatosis with polyangiitis | 2.6% |
| 198 | Dermatitis, Allergic Contact | 2.6% |
| 199 | HIV Seropositivity | 2.6% |
| 200 | Atypical Hemolytic Uremic Syndrome | 2.5% |
| 201 | Leukemia, Myelomonocytic, Chronic | 2.5% |
| 202 | Myasthenia Gravis, Autoimmune, Experimental | 2.5% |
| 203 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.5% |
| 204 | Febrile Neutropenia | 2.5% |
| 205 | Mastocytosis, Systemic | 2.4% |
| 206 | Stiff-Person Syndrome | 2.3% |
| 207 | Polyradiculoneuropathy | 2.3% |
| 208 | Polyradiculoneuritis | 2.3% |
| 209 | Ataxia Telangiectasia | 2.2% |
| 210 | Acquired Immunodeficiency Syndrome | 2.2% |
| 211 | AIDS related complex | 2.2% |
| 212 | Felty Syndrome | 2.2% |
| 213 | Lupus Nephritis | 2.2% |
| 214 | Acute Chest Syndrome | 2.2% |
| 215 | Pulmonary Eosinophilia | 2.1% |
| 216 | Eosinophilic Pneumonia | 2.1% |
| 217 | Waterhouse-Friderichsen Syndrome | 2.1% |
| 218 | Leukemia, Myeloid, Chronic-Phase | 2% |
| 219 | Anemia, Pernicious | 2% |
| 220 | Eosinophilia-Myalgia Syndrome | 2% |
| 221 | Angioedema | 2% |
| 222 | Multiple Sclerosis | 2% |
| 223 | Shwartzman Phenomenon | 2% |
| 224 | Niemann-Pick Disease, Type C | 2% |
| 225 | Hemangioma, Cavernous | 2% |
| 226 | Scurvy | 2% |
| 227 | Purpura Fulminans | 2% |
| 228 | Acute Generalized Exanthematous Pustulosis | 2% |
| 229 | AIDS-Related Opportunistic Infections | 1.9% |
| 230 | Vasculitis, Central Nervous System | 1.9% |
| 231 | Dermatitis, Atopic | 1.9% |
| 232 | HIV Wasting Syndrome | 1.9% |
| 233 | Rheumatoid Vasculitis | 1.9% |
| 234 | AIDS Dementia Complex | 1.9% |
| 235 | AIDS-Associated Nephropathy | 1.9% |
| 236 | Neuromyelitis Optica | 1.8% |
| 237 | Leukoencephalitis, Acute Hemorrhagic | 1.8% |
| 238 | Lupus Vasculitis, Central Nervous System | 1.8% |
| 239 | Asthma | 1.7% |
| 240 | Lambert-Eaton Myasthenic Syndrome | 1.7% |
| 241 | Asthma, Exercise-Induced | 1.7% |
| 242 | Status Asthmaticus | 1.7% |
| 243 | Sicca Syndrome | 1.6% |
| 244 | Sjogren's Syndrome | 1.6% |
| 245 | Encephalomyelitis, Acute Disseminated | 1.6% |
| 246 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1.6% |
| 247 | Erythema Nodosum | 1.6% |
| 248 | Neuritis, Autoimmune, Experimental | 1.6% |
| 249 | Dermatitis, Photoallergic | 1.6% |
| 250 | HIV-Associated Lipodystrophy Syndrome | 1.6% |
| 251 | Multiple Sclerosis, Chronic Progressive | 1.6% |
| 252 | Multiple Sclerosis, Relapsing-Remitting | 1.6% |
| 253 | Hereditary Angioedema Type III | 1.5% |
| 254 | Hereditary Angioedema Types I and II | 1.5% |
| 255 | Asthma, Occupational | 1.4% |
| 256 | Aspergillosis, Allergic Bronchopulmonary | 1.4% |
| 257 | Guillain-Barre Syndrome | 1.4% |
| 258 | Farmer's Lung | 1.4% |
| 259 | Angioedemas, Hereditary | 1.4% |
| 260 | Hay fever | 1.4% |
| 261 | Rhinitis, Allergic, Perennial | 1.4% |
| 262 | Toxic Epidermal Necrolysis | 1.2% |
| 263 | Stevens-Johnson Syndrome | 1.2% |
| 264 | Pseudoxanthoma Elasticum | 1.1% |
| 265 | Giant Cell Arteritis | 1.1% |
| 266 | Temporal Arteritis | 1.1% |
| 267 | Myelitis, Transverse | 1% |
| 268 | Miller Fisher Syndrome | 0.8% |